RxDoctor Payments Data

Teresa Landrum, APRN

Family · Barbourville, KYNPI 1548724537

Payments from drug & device makers

$447in general payments, 2019–2025

Across 23 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$98
  • Bayer$59
  • Alkermes, Inc.$57
  • Teva Pharmaceuticals USA, Inc.$44
  • Sumitomo Pharma America, Inc.$35
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$35
  • plus $119 from 7 others

What the payments were for

  • Food & beverage$447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$447 in reported general payments places this provider in the 45th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$379
Medicare patients
13
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide19$20,695
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen107$1,747
Albuterol Sulfate HfaAlbuterol Sulfate36$1,228
Gabapentin84$777
Ventolin HfaAlbuterol Sulfate11$716
Levothyroxine Sodium27$568
Phenytoin Sodium Extended16$423
Celecoxib22$411
Omeprazole33$316
Azelastine Hcl15$294
Lisinopril45$294
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$291
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$277
Mirtazapine22$273
Fluticasone Propionate17$245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$17$20,69519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 4,374 family providers in Kentucky.

Other family in Barbourville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →